[{"id":"d5f97284-f241-4922-aff7-91252d0fa774","acronym":"","url":"https://clinicaltrials.gov/study/NCT01700946","created_at":"2021-01-18T07:23:42.396Z","updated_at":"2024-07-02T16:36:03.318Z","phase":"Phase 2","brief_title":"Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma","source_id_and_acronym":"NCT01700946","lead_sponsor":"St. Jude Children's Research Hospital","biomarkers":" CD20","pipe":" | ","alterations":" CD20 expression","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Rituxan (rituximab) • cytarabine • cyclophosphamide • etoposide IV • methotrexate • vincristine • clofarabine • mitoxantrone • Oncaspar liquid (pegaspargase) • Vumon (teniposide) • mercaptopurine • vinblastine • Proleukin (aldesleukin) • cyclophosphamide intravenous"],"overall_status":"Completed","enrollment":" Enrollment 80","initiation":"Initiation: 04/15/2013","start_date":" 04/15/2013","primary_txt":" Primary completion: 07/24/2021","primary_completion_date":" 07/24/2021","study_txt":" Completion: 07/24/2021","study_completion_date":" 07/24/2021","last_update_posted":"2022-09-28"},{"id":"70a14a13-f51d-4a8e-b7a5-ae3fdaedca67","acronym":"","url":"https://clinicaltrials.gov/study/NCT02788201","created_at":"2021-01-29T07:12:16.767Z","updated_at":"2024-07-02T16:36:38.979Z","phase":"Phase 2","brief_title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","source_id_and_acronym":"NCT02788201","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • Xalkori (crizotinib) • erlotinib • carboplatin • sorafenib • paclitaxel • docetaxel • sunitinib • tamoxifen • cytarabine • bortezomib • doxorubicin hydrochloride • azacitidine • Jakafi (ruxolitinib) • oxaliplatin • irinotecan • Halaven (eribulin mesylate) • epirubicin • carmustine • Vumon (teniposide) • hydroxyurea • Zanosar (streptozocin)"],"overall_status":"Completed","enrollment":" Enrollment 8","initiation":"Initiation: 03/27/2017","start_date":" 03/27/2017","primary_txt":" Primary completion: 10/23/2019","primary_completion_date":" 10/23/2019","study_txt":" Completion: 10/23/2019","study_completion_date":" 10/23/2019","last_update_posted":"2020-11-06"}]